Multigate: A$4.2m–6.8m EBIT opportunity identified

Case study summary

Pricing Insight worked with Multigate to assess pricing capability and identify A$4.2m–6.8m of EBIT improvement potential across products and procedure-pack pricing.

Results at a glance

• Status: Identified opportunity, not realised profit.
• EBIT potential: A$4.2m–6.8m.
• Outputs: Value tools, quoting guidance, authority models and dashboard designs.

Client context

Multigate’s current website describes procedure packs and medical consumables for public and private hospitals, including wound management, anaesthetics and cardiovascular applications. Pack composition and clinical application provide concrete context for commercial complexity.

What pricing challenge did Multigate face?

Cost-plus tendering and inconsistent pack pricing did not consistently recognise customisation, service requirements or customer value.

What did Pricing Insight do?

The work combined capability assessment, stakeholder interviews and analysis of pricing structures and overrides. Pricing Insight developed value-driver maps, tender-authority models, quoting tools and a prioritised roadmap.

What changed or was identified?

The engagement account identifies financial potential and describes capability tools. Delivered designs do not establish that every recommendation was implemented.

How was the opportunity measured?

The complete opportunity calculation and a realised financial reconciliation are not publicly disclosed. A diagnostic baseline alone cannot establish improved maturity without a comparable follow-up assessment.

Pricing Insight Periodic Table

Relevant capabilities: Tender and project pricing (Tp), Price-setting method (Md), and Discount authority and controls (Da). This current framework mapping is retrospective.

Lessons and next step

Connect pack and tender decisions to clear value, scope and approval rules; verify benefit after implementation.

Current context: Multigate procedure packs, reviewed 24 October 2026. Contact Pricing Insight.